The snus had a nice tobacco taste with hints of vanilla, herbs, chocolate and some roasted coffee and dark wood. Marlboro snus was originally created by the American producer, Philip Morris, and was primarily aimed for the American palate. To clarify, this snus product is not the same as the Swedish Match version of Marlboro that has unfortunately been discontinued. The brand consists of four different flavours and formats — peppermint, spearmint, rich and mild. These are not available for purchase on our website but we offer a great deal of other products that all have better taste, comfort, quality and that above all ensure a satisfying nicotine experience.
General is a high quality snus brand manufactured by the snus giant Swedish Match, where all snus products go through stringent quality controls before leaving the factory. In Sweden, snus is also regulated as a food product and contain detailed information of contents at the back of each can. You can therefore rest assured all the quality standards are being met! In contrast to Swedish snus, American products are known to be overly sweet, have lower nicotine levels and extremely dry pouches with little to no comfort.
The mint has a sweetness to it that is perfectly balanced with a little salt to accentuate the flavour. The nicotine is released evenly and over a long period due to the dry exterior of each pouch. Luckily, the presence of mint contributes to a long-lasting feeling of freshness and the moist content of each bag makes it comfortable under the lip. The dark tobacco taste is robust and has some spice to it. A truly tasty treat. It is therefore not in PM's financial interest for snus to become as successful in the U.
One way to avoid this is to market a product called snus without adequate delivery of the key ingredient, nicotine. Mass marketing of this product could potentially "vaccinate" U. Uniquely, PM is giving away coupons for free Marlboro snus tins and is even attaching free Marlboro snus samples to Marlboro cigarette packs. Another motive may be perceived reduction of litigation risks. If snus were to become as popular in the U.
One way to avoid such an argument having merit in court is to demonstrate that snus is not an acceptable alternative to cigarettes in the U. Concerns about the introduction of Swedish snus in the U. One issue focuses on the possibility that introducing a new, less harmful smokeless tobacco product will encourage use by young people. There is little doubt that snus will be used by young people just as cigarettes are.
However, in Sweden, snus use appears to be a pathway from smoking, rather than being a gateway to smoking [ 14 — 17 ]. Thus, it appears that Swedish snus has replaced smoking for many young people in Sweden. This is the very age-group with the highest smoking prevalence in the United States who would have a lot to gain by quitting smoking [ 26 ].
Perhaps the biggest threat to public health from new low nitrosamine snus stems from the possibility that it may foster persistent dual tobacco use instead of smoking cessation. As restrictions on cigarette smoking increase, smokers who might otherwise have quit may instead use snus at times when they cannot smoke.
A product delivering as little nicotine as PM snus will leave the smoker craving for a cigarette, possibly another part of PM's intention. Although dual cigarette and snus use is not the pattern emerging in Sweden [ 14 , 18 ], it is only recently that cigarette companies have simultaneously been marketing smokeless products in Sweden.
Dual use of cigarettes and snus is certainly a valid concern that needs to be monitored closely. Efforts to control tobacco-caused deaths and diseases continue to be hampered by inadequate regulatory control over tobacco products. The Royal College of Physicians RCP recently concluded that, "low nitrosamine smokeless tobacco products may have a positive role to play in a coordinated and regulated harm reduction strategy which maximizes public health benefit and protects against commercial market exploitation," p [ 11 ].
Right now in the United States, tobacco manufacturers can introduce new products, call them whatever they wish, and change product ingredients without adequate regulatory oversight or information for the public.
It is clear that the status quo is unacceptable and simply allows the tobacco industry to confuse the public about the nature of its products [ 27 ]. If Marlboro snus continues to deliver very low levels of nicotine then it will likely not appeal to smokers as an alternative to cigarettes, just as PM's brand of cigarettes with very low nicotine delivery Next was unsuccessful in the marketplace.
It is possible that PM intends for Marlboro snus to fail in the marketplace, and may even hope that the tobacco control lobby's criticism of snus will assist with its demise [ 7 , 28 , 29 ]. Criticism of snus by anti-tobacco groups may end up unwittingly supporting PM's efforts to maintain the cigarette-dominant status quo. In so doing, PM could prevent snus from challenging the dominance of cigarettes — a product that is at least ten times more harmful to health than snus [ 5 ], and the number one cause of premature death in the western world.
Tob Control. Broadstock EM: Systematic review of the health effects of modified smokeless tobacco products. Google Scholar. Article PubMed Google Scholar. Rodu B, Godshall WT: Tobacco harm reduction: an alternative cessation strategy for inveterate smokers.
Harm Reduct J. Cancer Epidemiol Biomarkers Prev. Martinet Y, Bohadana A, Fagerstrom K: Introducing oral tobacco for tobacco harm reduction: what are the main obstacles?.
Savage L: Experts fear Swedish snus sales in the U. J Natl Cancer Inst. PLoS Med. Nielsen AC: Study finds 43 brands have billion dollar global presence. Edited by: London: RCP. Psychopharmacology Berl. Lunell E, Lunell M: Steady-state nicotine plasma levels following use of four different types of Swedish snus compared with 2-mg Nicorette chewing gum: a crossover study. Nicotine Tob Res. Scand J Public Health.
J Intern Med. Fisher M: Snus smokeless tobacco products. Dunsby J, Bero L: A nicotine delivery device without the nicotine? Tobacco industry development of low nicotine cigarettes. Nelson L: If you think snus is a safe alternative to smoking, think again. The Kansas City Star. Foulds J, Kozlowski L: Snus--what should the public-health response be?. Kozlowski LT: Harm reduction, public health, and human rights: smokers have a right to be informed of significant harm reduction options.
Download references. His other current research funding also as P. The funding sources had no involvement in collection or interpretation of the data, and were not involved in the decision to submit this paper for publication. You can also search for this author in PubMed Google Scholar.
Correspondence to Helena Furberg. Jonathan Foulds has worked as a consultant and speaker for pharmaceutical companies involved in production of tobacco dependence treatment medications, as well as a variety of agencies involved in promoting health e. A number of these agencies have provided sponsorship funds for educational events conducted by the program he directs.
He has also worked as an expert witness in litigation, including for plaintiffs in law suits against tobacco companies. He has not received any funding from the tobacco industry other than deposition fees from defendants attorneys in litigation against the tobacco industry i.
He is paid for writing a regular column on a health website. She declares no conflict of interest. JF drafted the original manuscript and HF has been involved in revising it critically for important intellectual content.
Both authors read and approved the final version. This article is published under license to BioMed Central Ltd. Reprints and Permissions. Foulds, J. Is low-nicotine Marlboro snus really snus?. Harm Reduct J 5, 9 Download citation. Received : 29 November
0コメント